|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 13.81 CNY | -8.42% |
|
-9.44% | -4.69% |
Guilin Sanjin Pharmaceutical Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was CNY 2,171.75 million compared to CNY 1,959.73 million a year ago. Net income was CNY 390.75 million compared to CNY 329.53 million a year ago.
Basic earnings per share from continuing operations was CNY 0.67 compared to CNY 0.56 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -4.69% | 1.12B | |
| +35.04% | 5.92B | |
| -15.13% | 4.51B | |
| -9.75% | 3.15B | |
| +2.14% | 3.1B | |
| -6.82% | 2.42B | |
| +47.87% | 1.97B | |
| -7.89% | 1.68B | |
| +0.09% | 1.65B | |
| -12.97% | 1.53B |
GUILIN SANJIN PHARMACEUTICAL CO., LTD. 
